Zobrazeno 1 - 10
of 21
pro vyhledávání: '"LBO Alves"'
Autor:
LAPC Lage, RN Vita, CO Reichert, HF Culler, FA Freitas, LBO Alves, V Rocha, SAC Siqueira, RO Costa, J Pereira
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S237-S238 (2024)
Introduction: DLBCL commonly affects the older population. Elderly patients often present high-risk molecular profile, lower tolerability to chemotherapy, and poor outcomes. In this setting, attenuated therapeutic regimens, such as R-miniCHOP and R-m
Externí odkaz:
https://doaj.org/article/3a78da1cae29422bb0d71c7fbb2c6e35
Autor:
LAPC Lage, GC Barreto, HF Culler, JB Cavalcanti, LBO Alves, L Nardinelli, I Bendit, V Rocha, J Pereira
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S101-S102 (2021)
Introduction: Nodal-PTCL constitute a rare group of aggressive malignancies with heterogeneous clinical-biological presentation and outcomes. Recently its pathophysiological knowledge has been highly improved, with descriptions of gene mutations asso
Externí odkaz:
https://doaj.org/article/7b80d4eeda454aff8e415884aa4d35e4
Autor:
C Rothschild, AAGS Brandão, A Duran, AE Zerati, LA Hajjar, GF Saes, CS Bittar, IBSS Costa, SMR Fonseca, MHHDS Rehder, LBO Alves, MDPE Diz, J Pereira, V Rocha
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S243-S244 (2021)
Background: Cancer associated venous thrombosis (CAT) can affect 20% of oncologic patients. Its management is challenging due to coexistent risk of bleeding and thrombosis (VTE) recurrence, that are 6 and approximately 4 fold higher compared to non-c
Externí odkaz:
https://doaj.org/article/97b54ebebebd46d79def2afd7931a1f3
Autor:
AS Vieira, LM Nasser, CHS Almeida, CER Garces, FS Ghaname, JN Ghaname, MC Braga, LBO Alves, MC Mendonça, C Almeida-Neto
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S305- (2021)
Objetivos: A Spectra OPTIA é uma separadora celular que utiliza centrifugação de fluxo contínuo e tecnologia de detecção óptica e está disponível nos maiores serviços de aférese do mundo. Entretanto, no Brasil, estudos envolvendo este equi
Externí odkaz:
https://doaj.org/article/524424cc633444c8beab46838e3c9216
Autor:
C Almeida-Neto, GM Santos, DLF Silva, AL Albiero, DC Freitas, AA Barbosa, RC Martins, LBO Alves, V Rocha, A Mendrone-Junior
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S306- (2021)
Objetivos: A transfusão de concentrado de granulócitos (CG) é indicada em pacientes neutropênicos graves, em contexto de infecção refratária após 48h de tratamento com antimicrobiano específico, sem previsão de recuperação neutrofílica p
Externí odkaz:
https://doaj.org/article/0ac0032fada548ffa5deabf8d7278689
Publikováno v:
Hematology, Transfusion and Cell Therapy. 44:S657-S658
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae6e439dd9e075584b9a63883e7fee3c
https://doi.org/10.1016/j.htct.2022.09.1129
https://doi.org/10.1016/j.htct.2022.09.1129
Autor:
MO Marques, A Abdo, PB Silva, AS Junior, LBO Alves, GN Arruda, LMCR Brasil, P Bachour, OC Baiocchi
Publikováno v:
Hematology, Transfusion and Cell Therapy. 44:S656-S657
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::238c1669796bf8c365e710d97f966a01
https://doi.org/10.1016/j.htct.2022.09.1128
https://doi.org/10.1016/j.htct.2022.09.1128
Autor:
LAPC Lage, RN Vita, LBO Alves, MD Jacomassi, HF Culler, CO Reichert, RO Costa, SAC Siqueira, V Rocha, J Pereira
Publikováno v:
Hematology, Transfusion and Cell Therapy. 44:S97-S98
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3051df7c8b2d647296fe6a870005c89f
https://doi.org/10.1016/j.htct.2022.09.163
https://doi.org/10.1016/j.htct.2022.09.163
Autor:
Vanderson Rocha, Dlf Silva, Lbo Alves, G. M. Santos, AA Barbosa, RC Martins, Alfredo Mendrone-Junior, A.L.M. Albiero, DC Freitas, Cesar de Almeida-Neto
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S306-(2021)
Objetivos: A transfusão de concentrado de granulócitos (CG) é indicada em pacientes neutropênicos graves, em contexto de infecção refratária após 48h de tratamento com antimicrobiano específico, sem previsão de recuperação neutrofílica p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bddaf933b292bd2a70ff69a67d5a8e56
http://www.sciencedirect.com/science/article/pii/S2531137921006659
http://www.sciencedirect.com/science/article/pii/S2531137921006659
Autor:
Vanderson Rocha, Lbo Alves, Luciana Nardinelli, Israel Bendit, GC Barreto, JB Cavalcanti, Hebert Fabricio Culler, Lapc Lage, Juliana Pereira
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S101-S102 (2021)
Introduction: Nodal-PTCL constitute a rare group of aggressive malignancies with heterogeneous clinical-biological presentation and outcomes. Recently its pathophysiological knowledge has been highly improved, with descriptions of gene mutations asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90ccf59966d4bb22948c9c20fc7c1ac9
http://www.sciencedirect.com/science/article/pii/S2531137921003199
http://www.sciencedirect.com/science/article/pii/S2531137921003199